Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.38) by 39.47 percent. This is a 42.5 percent increase over losses of $(0.40) per share from the same period last year.
- Company Dashboard
- Filings
- Patents
-
Article
Context Therapeutics Q1 EPS $(0.23) Beats $(0.38) Estimate
Company Profile